(Q50791879)
Statements
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension (English)
1 reference
Andrew J Palmer
1 reference
William J Valentine
1 reference
Daniel M D Tucker
1 reference
Joshua A Ray
1 reference
Stéphane Roze
1 reference
Lieven Annemans
1 reference
Pablo Lapuerta
1 reference
Roland Chen
1 reference
Sylvie Gabriel
1 reference
Paulo Carita
1 reference
Roger A Rodby
1 reference
Dick de Zeeuw
1 reference
Hans-Henrik Parving
1 reference
Maurice Laville
1 reference
1 November 2006
1 reference
22
1 reference
11
1 reference
2095-2100
1 reference